Skip to main content
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1989 Apr;2(Suppl):S112–S117. doi: 10.1128/cmr.2.suppl.s112

Molecular basis for serum resistance in Neisseria gonorrhoeae.

P A Rice 1
PMCID: PMC358087  PMID: 2497955

Full text

PDF
S112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apicella M. A., Westerink M. A., Morse S. A., Schneider H., Rice P. A., Griffiss J. M. Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae. J Infect Dis. 1986 Mar;153(3):520–526. doi: 10.1093/infdis/153.3.520. [DOI] [PubMed] [Google Scholar]
  2. Brogadir S. P., Schimmer B. M., Myers A. R. Spectrum of the gonococcal arthritis-dermatitis syndrome. Semin Arthritis Rheum. 1979 Feb;8(3):177–183. doi: 10.1016/s0049-0172(79)80006-2. [DOI] [PubMed] [Google Scholar]
  3. Brown E. J., Berger M., Joiner K. A., Frank M. M. Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules. Infect Immun. 1983 Nov;42(2):594–598. doi: 10.1128/iai.42.2.594-598.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cannon J. G., Lee T. J., Guymon L. F., Sparling P. F. Genetics of serum resistance in Neisseria gonorrhoeae: the sac-1 genetic locus. Infect Immun. 1981 May;32(2):547–552. doi: 10.1128/iai.32.2.547-552.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cannon J. G., Sparling P. F. The genetics of the gonococcus. Annu Rev Microbiol. 1984;38:111–133. doi: 10.1146/annurev.mi.38.100184.000551. [DOI] [PubMed] [Google Scholar]
  6. Crawford C., Knapp J. S., Hale J., Holmes K. K. Asymptomatic gonorrhea in men: caused by gonococci with unique nutritional requirements. Science. 1977 Jun 17;196(4296):1352–1353. doi: 10.1126/science.405742. [DOI] [PubMed] [Google Scholar]
  7. Demarco de Hormaeche R., Bundell C., Chong H., Taylor D. W., Wildy P. Definition of a virulence-related antigen of Neisseria gonorrhoeae with monoclonal antibodies and lectins. J Infect Dis. 1986 Mar;153(3):535–546. doi: 10.1093/infdis/153.3.535. [DOI] [PubMed] [Google Scholar]
  8. Demarco de Hormaeche R., Jessop H., Senior K. Gonococcal variants selected by growth in vivo or in vitro have antigenically different LPS. Microb Pathog. 1988 Apr;4(4):289–297. doi: 10.1016/0882-4010(88)90089-7. [DOI] [PubMed] [Google Scholar]
  9. Densen P., Gulati S., Rice P. A. Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. Role of antibodies directed against lipooligosaccharides. J Clin Invest. 1987 Jul;80(1):78–87. doi: 10.1172/JCI113067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Densen P., MacKeen L. A., Clark R. A. Dissemination of gonococcal infection is associated with delayed stimulation of complement-dependent neutrophil chemotaxis in vitro. Infect Immun. 1982 Nov;38(2):563–572. doi: 10.1128/iai.38.2.563-572.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Densen P., McRill C. M., Ross S. C. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae. J Immunol. 1988 Dec 1;141(11):3902–3909. [PubMed] [Google Scholar]
  12. Eisenstein B. I., Masi A. T. Disseminated gonococcal infection (DGI) and gonococcal arthritis (GCA): I. Bacteriology, epidemiology, host factors, pathogen factors, and pathology. Semin Arthritis Rheum. 1981 Feb;10(3):155–172. doi: 10.1016/s0049-0172(81)80001-7. [DOI] [PubMed] [Google Scholar]
  13. Fries L. F., Gaither T. A., Hammer C. H., Frank M. M. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I. J Exp Med. 1984 Dec 1;160(6):1640–1655. doi: 10.1084/jem.160.6.1640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Glynn A. A., Ward M. E. Nature and Heterogeneity of the Antigens of Neisseria gonorrhoeae Involved in the Serum Bactericidal Reaction. Infect Immun. 1970 Aug;2(2):162–168. doi: 10.1128/iai.2.2.162-168.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gotschlich E. C., Seiff M., Blake M. S. The DNA sequence of the structural gene of gonococcal protein III and the flanking region containing a repetitive sequence. Homology of protein III with enterobacterial OmpA proteins. J Exp Med. 1987 Feb 1;165(2):471–482. doi: 10.1084/jem.165.2.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gresham H. D., Renfer L., Hammer C. H., Frank M. M. Terminal complement components play a role in the expression of C5a. J Immunol. 1987 Feb 1;138(3):838–841. [PubMed] [Google Scholar]
  17. Griffiss J. M., O'Brien J. P., Yamasaki R., Williams G. D., Rice P. A., Schneider H. Physical heterogeneity of neisserial lipooligosaccharides reflects oligosaccharides that differ in apparent molecular weight, chemical composition, and antigenic expression. Infect Immun. 1987 Aug;55(8):1792–1800. doi: 10.1128/iai.55.8.1792-1800.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harriman G. R., Podack E. R., Braude A. I., Corbeil L. C., Esser A. F., Curd J. G. Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death. J Exp Med. 1982 Oct 1;156(4):1235–1249. doi: 10.1084/jem.156.4.1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hook E. W., 3rd, Olsen D. A., Buchanan T. M. Analysis of the antigen specificity of the human serum immunoglobulin G immune response to complicated gonococcal infection. Infect Immun. 1984 Feb;43(2):706–709. doi: 10.1128/iai.43.2.706-709.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Joiner K. A., Fries L. F., Schmetz M. A., Frank M. M. IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111. J Exp Med. 1985 Sep 1;162(3):877–889. doi: 10.1084/jem.162.3.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Joiner K. A., Scales R., Warren K. A., Frank M. M., Rice P. A. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J Clin Invest. 1985 Nov;76(5):1765–1772. doi: 10.1172/JCI112167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Joiner K. A., Warren K. A., Brown E. J., Swanson J., Frank M. M. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. J Immunol. 1983 Sep;131(3):1443–1451. [PubMed] [Google Scholar]
  23. Joiner K. A., Warren K. A., Hammer C., Frank M. M. Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. J Immunol. 1985 Mar;134(3):1920–1925. [PubMed] [Google Scholar]
  24. Joiner K. A., Warren K. A., Tam M., Frank M. M. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity. J Immunol. 1985 May;134(5):3411–3419. [PubMed] [Google Scholar]
  25. Judd R. C. 125I-peptide mapping of protein III isolated from four strains of Neisseria gonorrhoeae. Infect Immun. 1982 Aug;37(2):622–631. doi: 10.1128/iai.37.2.622-631.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Judd R. C. Surface peptide mapping of protein I and protein III of four strains of Neisseria gonorrhoeae. Infect Immun. 1982 Aug;37(2):632–641. doi: 10.1128/iai.37.2.632-641.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Martin P. M., Patel P. V., Clay J. C., Parsons N. J., Smith H. Induction by human serum of resistance to serum in Neisseria gonorrhoeae: A clinical survey of patients with gonorrhoea. Br J Vener Dis. 1984 Jun;60(3):151–153. doi: 10.1136/sti.60.3.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Martin P. M., Patel P. V., Parsons N. J., Smith H. Induction in gonococci of phenotypic resistance to killing by human serum by human genital secretions. Br J Vener Dis. 1982 Dec;58(6):363–365. doi: 10.1136/sti.58.6.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Martin P. M., Patel P. V., Parsons N. J., Smith H. Induction of phenotypically determined resistance of Neisseria gonorrhoeae to human serum by factors in human serum. J Gen Microbiol. 1981 Nov;127(1):213–217. doi: 10.1099/00221287-127-1-213. [DOI] [PubMed] [Google Scholar]
  30. Martin P. M., Patel P. V., Parsons N. J., Smith H. Induction of serum resistance in recent isolates of Neisseria gonorrhoeae by a low-molecular-weight fraction of guinea pig serum. J Infect Dis. 1983 Aug;148(2):334–334. doi: 10.1093/infdis/148.2.334. [DOI] [PubMed] [Google Scholar]
  31. McCutchan J. A., Katzenstein D., Norquist D., Chikami G., Wunderlich A., Braude A. I. Role of blocking antibody in disseminated gonococcal infection. J Immunol. 1978 Nov;121(5):1884–1888. [PubMed] [Google Scholar]
  32. McShan W. M., Williams R. P., Hull R. A. A recombinant molecule from a disseminating strain of Neisseria gonorrhoeae that confers serum bactericidal resistance. Infect Immun. 1987 Dec;55(12):3017–3022. doi: 10.1128/iai.55.12.3017-3022.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Morse S. A., Apicella M. A. Isolation of a lipopolysaccharide mutant of Neisseria gonorrhoeae: an analysis of the antigenic and biologic difference. J Infect Dis. 1982 Feb;145(2):206–216. doi: 10.1093/infdis/145.2.206. [DOI] [PubMed] [Google Scholar]
  34. Morse S. A., Mintz C. S., Sarafian S. K., Bartenstein L., Bertram M., Apicella M. A. Effect of dilution rate on lipopolysaccharide and serum resistance of Neisseria gonorrhoeae grown in continuous culture. Infect Immun. 1983 Jul;41(1):74–82. doi: 10.1128/iai.41.1.74-82.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Nairn C. A., Cole J. A., Patel P. V., Parsons N. J., Fox J. E., Smith H. Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum. J Gen Microbiol. 1988 Dec;134(12):3295–3306. doi: 10.1099/00221287-134-12-3295. [DOI] [PubMed] [Google Scholar]
  36. O'Brien J. P., Goldenberg D. L., Rice P. A. Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 1983 Nov;62(6):395–406. [PubMed] [Google Scholar]
  37. Parsons N. J., Patel P. V., Tan E. L., Andrade J. R., Nairn C. A., Goldner M., Cole J. A., Smith H. Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Microb Pathog. 1988 Oct;5(4):303–309. doi: 10.1016/0882-4010(88)90103-9. [DOI] [PubMed] [Google Scholar]
  38. Rice P. A., Goldenberg D. L. Clinical manifestations of disseminated infection caused by Neisseria gonorrhoeae are linked to differences in bactericidal reactivity of infecting strains. Ann Intern Med. 1981 Aug;95(2):175–178. doi: 10.7326/0003-4819-95-2-175. [DOI] [PubMed] [Google Scholar]
  39. Rice P. A., Kasper D. L. Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection. J Clin Invest. 1977 Nov;60(5):1149–1158. doi: 10.1172/JCI108867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rice P. A., Kasper D. L. Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins. J Clin Invest. 1982 Jul;70(1):157–167. doi: 10.1172/JCI110589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rice P. A., McCormack W. M., Kasper D. L. Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease. J Immunol. 1980 May;124(5):2105–2109. [PubMed] [Google Scholar]
  42. Rice P. A., Vayo H. E., Tam M. R., Blake M. S. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J Exp Med. 1986 Nov 1;164(5):1735–1748. doi: 10.1084/jem.164.5.1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rittenberg S. C., Penn C. W., Parsons N. J., Veale D. R., Smith H. Phenotypic changes in the resistance of Neisseria gonorrhoeae to killing by normal human serum. J Gen Microbiol. 1977 Nov;103(1):69–75. doi: 10.1099/00221287-103-1-69. [DOI] [PubMed] [Google Scholar]
  44. Ross S. C., Densen P. Opsonophagocytosis of Neisseria gonorrhoeae: interaction of local and disseminated isolates with complement and neutrophils. J Infect Dis. 1985 Jan;151(1):33–41. doi: 10.1093/infdis/151.1.33. [DOI] [PubMed] [Google Scholar]
  45. Schneider H., Griffiss J. M., Mandrell R. E., Jarvis G. A. Elaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae. Infect Immun. 1985 Dec;50(3):672–677. doi: 10.1128/iai.50.3.672-677.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Schoolnik G. K., Buchanan T. M., Holmes K. K. Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest. 1976 Nov;58(5):1163–1173. doi: 10.1172/JCI108569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Shafer W. M., Guymon L. F., Sparling P. F. Identification of a new genetic site (sac-3+) in Neisseria gonorrhoeae that affects sensitivity to normal human serum. Infect Immun. 1982 Mar;35(3):764–769. doi: 10.1128/iai.35.3.764-769.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Shafer W. M., Joiner K., Guymon L. F., Cohen M. S., Sparling P. F. Serum sensitivity of Neisseria gonorrhoeae: the role of lipopolysaccharide. J Infect Dis. 1984 Feb;149(2):175–183. doi: 10.1093/infdis/149.2.175. [DOI] [PubMed] [Google Scholar]
  49. Stein D. C., Petricoin E. F., Griffiss J. M., Schneider H. Use of transformation to construct Neisseria gonorrhoeae strains with altered lipooligosaccharides. Infect Immun. 1988 Apr;56(4):762–765. doi: 10.1128/iai.56.4.762-765.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Stephens D. S., Shafer W. M. Evidence that the serum resistance genetic locus sac-3 of Neisseria gonorrhoeae is involved in lipopolysaccharide structure. J Gen Microbiol. 1987 Sep;133(9):2671–2678. doi: 10.1099/00221287-133-9-2671. [DOI] [PubMed] [Google Scholar]
  51. Swanson J., Mayer L. W., Tam M. R. Antigenicity of Neisseria gonorrhoeae outer membrane protein(s) III detected by immunoprecipitation and Western blot transfer with a monoclonal antibody. Infect Immun. 1982 Nov;38(2):668–672. doi: 10.1128/iai.38.2.668-672.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tan E. L., Patel P. V., Parsons N. J., Martin P. M., Smith H. Lipopolysaccharide alteration is associated with induced resistance of Neisseria gonorrhoeae to killing by human serum. J Gen Microbiol. 1986 May;132(5):1407–1413. doi: 10.1099/00221287-132-5-1407. [DOI] [PubMed] [Google Scholar]
  53. Tramont E. C., Ciak J., Boslego J., McChesney D. G., Brinton C. C., Zollinger W. Antigenic specificity of antibodies in vaginal secretions during infection with Neisseria gonorrhoeae. J Infect Dis. 1980 Jul;142(1):23–31. doi: 10.1093/infdis/142.1.23. [DOI] [PubMed] [Google Scholar]
  54. Tramont E. C., Sadoff J. C., Artenstein M. S. Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction. J Infect Dis. 1974 Sep;130(3):240–247. doi: 10.1093/infdis/130.3.240. [DOI] [PubMed] [Google Scholar]
  55. Ward M. E., Watt P. J., Glynn A. A. Gonococci in urethral exudates possess a virulence factor lost on subculture. Nature. 1970 Jul 25;227(5256):382–384. doi: 10.1038/227382a0. [DOI] [PubMed] [Google Scholar]
  56. Winstanley F. P., Blackwell C. C., Tan E. L., Patel P. V., Parsons N. J., Martin P. M., Smith H. Alteration of pyocin-sensitivity pattern of Neisseria gonorrhoeae is associated with induced resistance to killing by human serum. J Gen Microbiol. 1984 May;130(5):1303–1306. doi: 10.1099/00221287-130-5-1303. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES